Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial.
Bosi E, Bax G, Scionti L, Spallone V, Tesfaye S, Valensi P, Ziegler D; FREMS European Trial Study Group. Bosi E, et al. Among authors: valensi p. Diabetologia. 2013 Mar;56(3):467-75. doi: 10.1007/s00125-012-2795-7. Epub 2012 Dec 13. Diabetologia. 2013. PMID: 23238789 Free PMC article. Clinical Trial.
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management.
Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, Stevens M, Kempler P, Hilsted J, Tesfaye S, Low P, Valensi P; Toronto Consensus Panel on Diabetic Neuropathy. Spallone V, et al. Among authors: valensi p. Diabetes Metab Res Rev. 2011 Oct;27(7):639-53. doi: 10.1002/dmrr.1239. Diabetes Metab Res Rev. 2011. PMID: 21695768 Free article.
Methods of investigation for cardiac autonomic dysfunction in human research studies.
Bernardi L, Spallone V, Stevens M, Hilsted J, Frontoni S, Pop-Busui R, Ziegler D, Kempler P, Freeman R, Low P, Tesfaye S, Valensi P; Toronto Consensus Panel on Diabetic Neuropathy. Bernardi L, et al. Among authors: valensi p. Diabetes Metab Res Rev. 2011 Oct;27(7):654-64. doi: 10.1002/dmrr.1224. Diabetes Metab Res Rev. 2011. PMID: 21695761 Free article.
Acute and long-term effects of saxagliptin on a set of cardiovascular targets measured at fasting and post-prandially in obese patients with impaired glucose tolerance: A placebo-controlled study.
Rezki A, Cosson E, Fysekidis M, Chiheb S, Vicaut E, Valensi P. Rezki A, et al. Among authors: valensi p. Nutr Metab Cardiovasc Dis. 2021 Sep 22;31(10):2945-2958. doi: 10.1016/j.numecd.2021.06.017. Epub 2021 Jul 1. Nutr Metab Cardiovasc Dis. 2021. PMID: 34420816 Clinical Trial.
378 results